Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10532418)

  • 1. Expression of apoptosis and its related protein in astrocytic tumors.
    Takekawa Y; Sawada T; Sakurai I
    Brain Tumor Pathol; 1999; 16(1):11-6. PubMed ID: 10532418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
    Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
    J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of apoptotic pathways and c.Jun/JNK expression in malignant gliomas.
    Schiffer D; Ferracini R; Cavalla P
    Anticancer Res; 2001; 21(4A):2531-5. PubMed ID: 11724318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the pro-apoptotic protein ARTS in astrocytic tumors: correlation with malignancy grade and survival rate.
    Gottfried Y; Voldavsky E; Yodko L; Sabo E; Ben-Itzhak O; Larisch S
    Cancer; 2004 Dec; 101(11):2614-21. PubMed ID: 15517578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.
    Ellison DW; Steart PV; Gatter KC; Weller RO
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):352-61. PubMed ID: 7494604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in astrocytic neoplasms.
    Carroll RS; Zhang J; Chauncey BW; Chantziara K; Frosch MP; Black PM
    Acta Neurochir (Wien); 1997; 139(9):845-50. PubMed ID: 9351989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of EphA2 in human astrocytic tumors: correlation with pathologic grade, proliferation and apoptosis.
    Li X; Wang Y; Wang Y; Zhen H; Yang H; Fei Z; Zhang J; Liu W; Wang Y; Zhang X
    Tumour Biol; 2007; 28(3):165-72. PubMed ID: 17519535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
    Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
    J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
    Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
    Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axin induces cell death and reduces cell proliferation in astrocytoma by activating the p53 pathway.
    Zhang LY; Ye J; Zhang F; Li FF; Li H; Gu Y; Liu F; Chen GS; Li Q
    Int J Oncol; 2009 Jul; 35(1):25-32. PubMed ID: 19513548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma.
    Facoetti A; Ranza E; Nano R
    Anticancer Res; 2008; 28(1A):15-9. PubMed ID: 18383819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors.
    Faccion RS; Bernardo PS; de Lopes GPF; Bastos LS; Teixeira CL; de Oliveira JA; Fernandes PV; Dubois LG; Chimelli L; Maia RC
    Cell Oncol (Dordr); 2018 Apr; 41(2):141-157. PubMed ID: 29374392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival.
    Vlodavsky E; Soustiel JF
    J Neurooncol; 2007 Jan; 81(1):1-7. PubMed ID: 16868661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors.
    Khalid H; Shibata S; Kishikawa M; Yasunaga A; Iseki M; Hiura T
    Cancer; 1997 Dec; 80(11):2133-40. PubMed ID: 9392336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors.
    Fujita H; Koji T; Kitagawa N; Tsutsumi K; Abe K; Kaminogo M; Shibata S
    Cell Mol Neurobiol; 2002 Aug; 22(4):393-406. PubMed ID: 12507389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and Fas-ligand expression correlate to the histopathological grade of gastric smooth muscle tumors.
    Liu Y; Chen C; Chen C; Hsieh H; Chang C; Shyu J; Yen C; Harn H
    J Surg Res; 2001 Feb; 95(2):92-8. PubMed ID: 11162031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.